Menu
Back to Journals » Drug Design, Development and Therapy » Volume 13
Review
Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,768 | Dovepress* | 9,393+ | 1,674 | 11,067 | |
| PubMed Central* | 4,375 | 1,172 | 5,547 | ||
| Totals | 13,768 | 2,846 | 16,614 | ||
| *Since 23 July 2019 | |||||
View citations on PubMed and Google Scholar